Smoking Cessation Aids Survival Even Following a Cancer Diagnosis
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 5, 2024 -- Evidence-based smoking cessation treatment within six months of a cancer diagnosis maximizes survival benefit, according to a study published online Oct. 31 in JAMA Oncology.
Paul M. Cinciripini, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined the association between time of entry into a smoking cessation intervention following a cancer diagnosis and survival outcomes. The analysis included 4,526 currently smoking patients diagnosed with cancer and receiving cessation treatment.
The researchers found that survival over 15 years increased for those quitting smoking at three months (adjusted hazard ratio, 0.75), six months (adjusted hazard ratio, 0.79), and nine months (adjusted hazard ratio, 0.85) of follow-up. The optimal survival outcomes were seen among patients who received tobacco treatment within six months of a cancer diagnosis. Their survival increased from 2.1 years among continuing smokers (nonabstainers) to 3.9 years for patients who quit (abstainers), at the 75th percentile. When tobacco treatment began within six months to five years following diagnosis, similar but less pronounced outcomes were seen, with survival at the 75th percentile of 4.8 years for nonabstainers versus 6.0 years for abstainers.
"This study supports smoking cessation as an important early clinical intervention for patients after being diagnosed with cancer," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
32 Percent of U.S. Adults Consumed Fast Food on a Given Day in 2021 to 2023
FRIDAY, June 27, 2025 -- Over 30 percent of adults and children consumed fast food on a given day during August 2021 to August 2023, according to two reports from the National...
Disparities Seen in Continuous Glucose Monitor Rx by Language Preference
FRIDAY, June 27, 2025 -- For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language preference, with less access...
Survey Shows Few Adults Recognize Testicular Cancer as Affecting Young Men
FRIDAY, June 27, 2025 -- Only one in 10 U.S. adults correctly identified testicular cancer as most commonly affecting men under age 40, according to a survey released June16 by...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.